| Peer-Reviewed

DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits

Received: 9 July 2021    Accepted: 30 July 2021    Published: 13 August 2021
Views:       Downloads:
Abstract

Some plants metabolites serve as antiprotozoal and antitumour by binding to nuclear enzyme; DNA Topo I affecting DNA function and cell survival. This study was aimed at screening DNA binding interactions and DNA Topo I inhibitory activity of crude extracts from fruits of Annona muricata (L) and Annona squamosa (L) which can form the basis of developing efficacious, safe and low cost antiprotozoal and antitumor agents. Aqueous, Methanolic, Ethyl acetate and Hexane extracts from fruits of two hypothesized antiprotozoal and antitumour plants; Annona muricata (L) and Annona squamosa (L) were screened for DNA-binding interaction and DNA Topo I inhibition. For DNA-methyl green test, 50 µL crude extracts were incubated with 200 μL DNA-methyl green in darkness at 25°C for 24 hours. Absorbance decrease at 650 nm using UV-vis spectrophotometer was calculated as a percentage of untreated DNA-methyl green value whereas with IC50 calculated by regression analysis. For DNA Topo I inhibitory activity, crude extracts were incubated in 10 µg/mL with 0.5 µg of supercoiled pBR322 DNA and 1U of DNA Topo I at 37°C for 2 hours, reaction terminated using stop buffer containing 3% SDS, 60 mM EDTA, 50% glycerol, 0.25% bromophenol blue. Products were determined by electrophoresis on 1% agarose gel in Tris-acetate-EDTA (TAE) running buffer at 65 V/cm for 2 hours. 24 extracts were studied, percentage decrease in absorbance were between 18.14±2.67 - 38.06±1.47 (Aqueous), 17.14±2.67 - 41.01±1.09% (Methanolic), 9.05±1.67 - 20.50±2.01% (Ethyl acetate) and 4.04±1.12 - 10.09±1.39% (Hexane)., IC50 values were between 50 μg/mL – 100 μg/mL (6), 100 μg/mL – 150 μg/mL (8), 150 μg/mL – 200 μg/mL (7) and <200 μg/mL (3). The activity against DNA Topo I mediated relaxation of supercoiled pBR322 DNA at 5 µM, 25 µM and 100 µM observed in 8 hits with percentage decrease in absorbance between 17.14±2.67 - 40.01±1.09% with IC50 between 62.97±3.37 μg/mL - 131.37±10.77 μg/mL. The extracts of A. muricata and A. squamosa showed DNA Topo I inhibitory activities by inhibiting the relaxation of supercoiled DNA pBR322. However, further studies need to be conducted on the purified fractions of aqueous and methanolic extracts.

Published in Biochemistry and Molecular Biology (Volume 6, Issue 3)
DOI 10.11648/j.bmb.20210603.14
Page(s) 58-66
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Topoisomerase I Inhibitors, DNA-Binding, Annona squamosa, Annona muricata

References
[1] Wink M. (2012). Medicinal plants: A source of anti-parasitic secondary metabolites. Molecule, 17: 12771-12791.
[2] Xin L. T, Liu, L., Shao C. L., Yu, R. L., Chen F. L., Yue F. J., Wang U., Guo Z. L., Fan Y. C., Guan H. S.. Wang C. Y. (2017). Discovery of DNA topoisomerase I inhibitors with low toxicity based on virtual screening from natural products. Marine drugs, 17: 771-791.
[3] Attard, E. & Pacioni, P. (1996). The Phytochemical and in Vitro Pharmacological Testing of Maltese Medicinal Plants. Bioactive Compounds in Phytomedicine, 5: 94-112.
[4] Peebles K. A., Baker R. K., Kurz E. U., Schneider B. J., Kroll D. J. (2001). Catalytic inhibition of human DNA topoisomerase II by hypericin, a naphthodianthrone from St. John’s wort (Hypericum perforatum). Biochemical Pharmacology, 62 (8): 1059-1070.
[5] Kluza J., Baldeyrou B., Colson P., Rasoanaivo P., Mambu L., Frappier F., Bailly C. (2003): Cytotoxicity and DNA binding properties of the plant alkaloid burasaine. Eur J Pharm Sci, 20: 383–391.
[6] Cao R., Peng W., Chen H., Ma Y., Lui X., Hou X., Guan, H., Xu, A. (2005). DNA binding properties of 9-substituted harmine derivatives. Biochem Biophys Res Commun, 338: 1557–1563.
[7] Qin Y., Pang J. Y., Chen W. H., Cai Z., Jiang, Z. H. (2006). Synthesis, DNA binding affinities, and binding mode of berberine dimmers. Bioorg Med Chem, 14: 25–32.
[8] Yamada M., Hayashi K., Shogo I., Ken T., Tsutsui K., Ito T., Iinuma, M.. Nozaki H. (2006). Inhibitory Activity of Plant Stilbene Oligomers against DNA Topoisomerase II. Biol. Pharm. Bull, 29 (7): 1504-1507.
[9] Correa Y. M., Nino, J., Musauera, O. M. (2007). DNA interaction of plant extracts from Colombian flora. Pharmaceutical Biology, 45 (2): 1111-1115.
[10] Lampronti I., Khan M. T. H., Borgatti M., Bianch N., Gambari R. (2008). Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences. eCAM. 5 (3): 303–312.
[11] Pommier Y., Leo E., Zhang H., Marchand C. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol, 17: 421- 433.
[12] Kar I., Chattopadhyaya R. (2016). Effect of seven Indian plant extracts on Fenton reaction-mediated damage to DNA constituents. J Biol Struct Dyn, 10: 1-15.
[13] Roy P., Das S., Auddy R. G., Mukherjee A. (2012). Biological targeting and drug delivery in control of Leishmaniasis. Journal of Cell and Animal Biology, 6 (6): 73-87.
[14] Tiuman T. S., Santos A. O., Ueda-Nakamura T., Filho B. P., Nakamura C. V. (2011). Recent advances in leishmaniasis treatment. Int. J. Infect. Dis. 15: e525-e532.
[15] Alkathiri B., El-Khadragy M. F., Metwally D. M., Al-Olaya E. M., Bakhrebah M. A., Abdel-Moneim A. E. (2017). Pomegranate (Punica granatum) Juice Shows Antioxidant Activity against Cutaneous Leishmaniasis-Induced Oxidative Stress in Female BALB/c Mice. Int. J. Environ. Res. Public Health, 14, 1592.
[16] Chimbevo M. L., Karanja S. M. Malala J. B., Orwa J. A., Anjili C. O., Essuman S. (2018). Growth performance, metabolic efficiency and nutrient utilization of BALB/C mice infected with L. major fed with Annonaceae fruit pulp. International Journal of Tropical diseases and Health; 30 (2): 1-14.
[17] Walker J., Saravia N. G. (2004). Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents. J Parasitol, 90 (5): 1155-62.
[18] Wink, M. (2007). Molecular modes of action of cytotoxic alkaloids from DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance. Alkaloids, 64: 1- 48.
[19] Sen N., Banerjee B., Majumder H. K. (2008). Molecular analysis of programmed cell death by DNA topoisomerase inhibitors in Kinatoplatid parasite Leishmania. In Martin, M. P. Eds: Programmed cell death in protozoa. India, Landes Bioscience and Springer Science + Bussiness Media.
[20] Wink M., Schimmer O. (2010). Molecular modes of action of defensive secondary metabolites. In Function and Biotechnology of plant secondary metabolites; Wink, M. Eds. Wiley-Blackwell, oxford, UK, pg 1621-1691.
[21] Abdel-Moneim A. E. (2014). Azadirachta indica attenuates cisplatin-induced neurotoxicity in rats. Indian J. Pharmacol, 46: 316-321.
[22] Abdel-Moneim, A. E. (2014). Prevention of carbon tetrachloride (CCl4)-induced toxicity in testes of rats treated with Physalis peruviana L. fruit. Toxicol. Ind. Health, 32: 1064-1073.
[23] Abdel-Moneim A. E., El-Khadragy, M. F. (2013). The potential effects of pomegranate (Punica granatum) juice on carbon tetrachloride-induced nephrotoxicity in rats. J. Physiol. Biochem, 69: 359-370.
[24] Othman M. S., Na, A., Zaki, H. S., Abdel-Moneim A. E. (2014). Effect of Physalis peruviana L. on cadmium-induced testicular toxicity in rats. Biol. Trace Elem. Res, 159: 278–287.
[25] Chimbevo M. L., Karanja S. M., Orwa J. A., Anjili C. O. (2018). An in vitro and in vivo model of free radical scavenging activity of methanolic and aqueous extract of fruit pulp from Annona squamosa (L.) and Annona muricata (L.) growing in Coast region of Kenya. Journal of Medical and Biological Research; 18 (2): 1-143.
[26] Paiva C. N., Bozza M. T. (2014). Are reactive oxygen species always detrimental to pathogens? Antioxid. Redox Signal, 20: 1000–1037.
[27] Inacio J. D., Gervazoni L., Canto-Cavalheiro M. M., Almeida-Amaral, E. E. (2014). The effect of (+)-epigallocatechin 3-o-gallate in vitro and in vivo in leishmania braziliensis: Involvement of reactive oxygen species as a mechanism of action. PLoS Negl. Trop. Dis. 8: e3093.
[28] Chimbevo, M. L., Malala, J. B., Anjili, C. O., Orwa, J., Mibei, E. K., Ndeti, C. M., Muchiri, F. W., Oshule, P. S., Oginga, F. O., Otundo, D. O., Karanja S. M. (2017). Annonaceae Fruits Growing in Coast Region of Kenya as an Alternative Source of Dietary Carotenoids. International Journal of Food Science and Biotechnology Journal of Medical and Biological Research; 2 (5): 114-120.
[29] Kokwaro J. O. (1993). Medicinal plants of East Africa. 2nd Edn. East Africa Literature Bureau. Kampala, Nairobi and Dares Salam.
[30] Maundu P. M., Ngugi G. W. & Kabuye C. H. S. (1999). Traditional Food plants of Kenya. National museums of Kenya, Nairobi, Kenya, KENRIK.
[31] Owuor B. O. Kisangau D. P. (2006). Kenyan medicinal plants used as antivenin: a comparison of plant usage. Journal of Ethnobiology and Ethnomedicine, 2: 7.
[32] Chimbevo M. L. (2019). Efficacy and safety, nutritional and antioxidant activity of Kenyan Annona muricata (L.) And Annona squamosa (L.) Fruits extracts in Balb/c mice model of L. major leishmaniasis. PhD Thesis, School of Biomedical Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi Kenya.
[33] Arthur F. K. N., Woode E., Terlabi E. O., Larbie C. (2011). Evaluation of acute and subchtonic toxicity of Annona muricata (Linn.) aqueous extract in animals. Eur. J. Exp. Biol, 1 (4): 115-124.
[34] Arthur F. K. N., Woode E., Terlabi EO., Larbie C. (2012). Bilirubin lowering potential of Annona muricata (Linn.) in temporary jaundiced rats. American journal of pharmacology and toxicology, 7 (2): 33-40.
[35] Arthur F K. N., Woode E., Terlabi, O., Larbie, C. (2012). Evaluation of Hepatoprotective Effect of Aqueous Extract of Annona muricata (Linn.) Leaf Against Carbon Tetrachloride and Acetaminophen Induced Liver Damage. Journal of Natural Pharmaceuticals, 3 (1): 25 – 30.
[36] Mariod A. A., Abdelwahab S. I., Elkheir S., Ahmed Y. M., Fauzi P. N. M., Chuen C. S. (2012). Antioxidant activity of different parts from Annona squamosa, and Catunaregam nilotica methanolic extract. Acta Sci. Pol., Technol. Aliment, 11 (3): 249-257.
[37] Nawwar M., Ayoub N., Hussein S., Hashim A., El-Sharawy R., Wende K., Harms, M., Lindequist U. (2012). Flavonol triglycoside and investigation of the antioxidant and cell stimulating activities of Annona muricata Linn. Arch. Pharm. Res, 35: 761–767.
[38] Nandhakumar E., Indumathi P. (2013). In vitro Antioxidant Activities of Methanol and Aqueous Extract of Annona squamosa (L.) Fruit Pulp. Journal of Acupuncture and Meridian Studies, 6 (3): 142 – 148.
[39] Samuagam L., Khoo H. E., Akowuah, G. A., Okechukwu P. N., Yim, H. S. (2014). HPLC analysis of antioxidant compounds in some selected tropical fruits’ peel. Innovative Romanian Food Biotechnology, 14: 61-68.
[40] George A. P., Broadley R., Nissen R. (2006). Preliminary review of the health and medicinal benefits of Annona spp. possible paths to commercialization. A confidential report for the Australian Custard Apple Growers Association. Asian. Pac. J. Cancer. Prev. 2: 99-124.
[41] George V. C, Kumar D. R., Rajkumar V., Suresh P. K., Ashok K. (2012). Quantitative Assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. In normal and immortalized human cell lines. Asian. Pac. J. Cancer. Prev. 13: 699-704.
[42] Najmuddin S. U. F. S., Romli M. F., Hamid M., Alitheen, N. B., Afizan N. M., Abdrahman N. (2016). Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line. BMC Complementary and Alternative Medicine. 16: 311-325.
[43] Pinto A. C. de Q., Cordeiro de Andrade S. R. M., Ferreira F. R., Filgueiras H. A. de C., Alves R. E., Kinpara D. I. (2005). Annona species. International Centre for Underutilized Crops, University of Southampton, Southampton, UK.
[44] Muthaura C. N., Rukungaa G. M., Chhabra S. C., Mungai G. M., Njagi E. N. M. (2007). Traditional antimalarial phytotherapy remedies used by the Kwale community of the Kenyan Coast. Journal of Ethnopharmacology, 114: 377–386.
[45] Ugwu B. U., Okogun J. I., Kabiru A. Y., Ogbadoyi E. O. (2011). Evaluation of Therapeutic Potentials of Stem Bark Extracts of Annona senegalensisin Experimental Trypanosoma bruceibrucei Infection in Mice. British Journal of Pharmacology and Toxicology, 2 (2): 63-70.
[46] Vila-Nova N. S., de Morais S. M., Falcao M. J. C., Machado L. K. A., Bevilaqua C. M. L., Costa I. R. S., de Sousa-Brasil N. V. G. P. & de Andrade-Júnior. H. F. (2011). Leishmanicidal activity and cytotoxicity of compounds from two Annonacea species cultivated in Northeastern Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 44 (5): 567-571.
[47] Biba V. S., Lakshmi S., Dhanya G. S., Remani P. (2013). Phytochemical analysis of Annona squamosa seed extracts. Int. Res J Pharm. App Sci, 5: 29-31.
[48] Pastor N., Cortes F. (2002). DNA topoisomerase activities in Chinese hamster radiosensitive mutants after x-ray treatment. Cell Biology International, 26 (6): 547–555.
[49] Pyne, R. W., Murray, D. A., Harding, S. A., Baird, D. B. & Soutar, D. M. (2011). An introduction to GenStat for Windows. 14th Edn. VSN International, Hemel Hempstead, UK.
[50] Ajaiyeoba, E., Mofolusho, F., Ogbole, O., Okpako, L. & Akinboye, D. (2006): In vivo antimalarial and cytotoxic properties of Annona senegalensis extract. African Journal of Traditional, Complementary and Alternative Medicines, 3 (1): 137-141.
[51] Adewole S. O. & Ojewole J. A. O. (2009). Protective effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on serum lipid profiles and oxidative stress in hepatocytes of streptozotocin-treated diabetic rats. Afr. J. Trad. CAM, 6 (1): 30 - 41.
[52] Shapaz S., Bories C., Loiseau, P. M., Cortes, D., Hocquemiller, R., Laurens, A. & Cave, A. (1994). Cytotoxic and antiparasitic activity from Annona senegalensis seeds. Planta Medica, 60 (6): 538-540.
[53] De Lima, J. P. S., Pinheiro, M. L. B., Santos, A. M. G., Pereira, J. L. S., Santos, D. M. F., Barison, A., Siva-Jardim, I. & Costa, E. V. (2012). In vitro antileshimanial and cytotoxic Activities of Annona mucosa. (Annonaceae). Rev. Virtual. Quim, 4 (6): 692-702.
[54] Jaramillo, M., Arango, G., Gonzalez, M., Robledo, S. & Velez, I. D. (2000). Cytotoxicity and antileishmanial activity of Annona muricata pericarp. Fitoterapia, 71 (2): 183-186.
[55] Osorio, E., Arango, G. J., Jimenez, N., Alzate, F., Ruiz, G., Gutierrez, D., Paco, M. A., Gimenez, A. & Robledo, S. (2007). Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae. Journal of Ethno Pharmacology, 111: 630-635.
[56] Igwe, A. C., Onabanjo, A. O. (1989). Chemotherapeutic effects of Annona senegalensi in Trypanosoma brucei brucei. AnnTrop med parasitol, 83 (5): 527-534.
[57] Rupprecht, J. K., Hui, Y. H., McLaughlin, J. L. (1990). Annonaceous acetogenins: a review. J. Nat. Prod, 53: 237-278.
[58] Chang F. R., Wu Y. C. Duh, C. Y. (1993). Studies of the acetogenins of Formosan Annonaceous plants. II. Cytotoxic Acetogenins from Annona muricata. Journal of Natural products, 56 (10): 1688-1694.
[59] Shapaz, S., Gonzalez, M. C., Hocquemiller, R., Zafra-Polo, M. C. & Cortes, D. (1996). Annosenegalin and Annogalene: two cytotoxic monotetrahydrofuran acetogenins from Annona senegalensis and Annona cherimolla. Phytochemistry, 42: 106-107.
[60] Coria-Tellez A. V., Montalvo-Gonzalez E., Yahia E. M., Obledo-Vazquez E. N. Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arabian Journal of Chemistry, 2018.
[61] Kurnick B., Foster M. (1950). Methyl green. III. Reaction with deoxyribonucleic acid: Stoichiometry and behavior of the reaction product. Journal of General Physiology, 34: 147-159.
[62] Kurnick N. (1950). The determination of desoxyribonuclease activity by methyl green: Application to Serum. Archives of Biochemistry, 29: 41-53.
[63] Krey, A. K., Hahn, F. E. (1975). Studies on the methyl green-DNA complex and its dissociation by drugs. Biochemistry, 14 (23): 5061 – 5067.
[64] Burres N. S., Frigo, A., Rasmussen, R. R., Mc Alpine J. B. (1992). A colorimetric microassay or the detection of agents that interact with DNA. Journal of Natural Products, 55 (11): 1582–1587.
[65] Goda F. E., Badria F. A. (2005). Synthesis and Biological Evaluation of Certain New Substituted Pyrido-[2, 3-D]-Pyrimidin-4 (1h)-One and Pyrido [2, 3-D]- Triazolo-[3, 4- B]-Pyrimidine Analogs. Saudi Pharmaceutical Journal, 13 (2- 3): 65-73.
[66] Chimbevo M. L. Essuman S. (2019). Preliminary Screening of Nutraceutical Potential of Fruit Pulp, Peel and Seeds from Annona Squamosa (L.) and Annona Muricata (L.) Growing in Coast Region of Kenya. American Journal of BioSciences; 7 (3): 58-70.
[67] Berger J. M. (2001). Isolation, Characterization, and Synthesis of Bioactive Natural Products from Rainforest Flora. PhD Thesis, Virginia Tech Department of Chemistry, Virginia Polytechnic Institute and State University.
[68] Frei E., Bieler C. A., Arlt V. M., Wiessler M., Stiborova M. (2002). Covalent binding of the anticancer drug ellipticine to DNA in V79 cells with human cytochrome P450 enzymes. Biochem Pharmacol, 64: 289–295.
[69] Ishida K., Asao T. (2002). Self-association and unique DNA binding properties of the anti-cancer agents TAS-103, a dual inhibitor of topoisomerases I and II. Biochem Biophys Acta, 1587: 155–163.
[70] Tayeb H., Salerno M., Priebe W., Kozlowski H., Garnier-Suillerot A. (2003). New findings in the study of the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA. Chem Biol Interact, 145: 349–358.
[71] Ni Y., Lin D., Kokot S. (2006). Synchronous fluorescence, UV-visible spectophotometric, and voltametric studies of the competitive interaction of bis- (1, 10-phenanthroline)-copper (II) complex and neutral red with DNA. Anal Biochem, 352: 231–242.
[72] Banerjee M., Faraha, A. A., Kumar A., Wenzler T., Brun R., Munde M. M., Wilson W. D., Zhu X., Werbovetz K. A., Boykin D. W. (2012). Synthesis, 162 DNA binding and antileishmanial activity of low molecular weight bisarylimidamides. Eur J Med Chem, 55: 449–454.
[73] Sarkar R., Mandal N. (2011). In vitro cytotoxic effect of hydro-alcoholic extracts of medicinal plants on Ehrlich’s Ascites Carcinoma (EAC). Int. J. Phytomed, 3: 370-380.
[74] Ghate N. B., Hazra B., Sarkar, R., Mandal N. (2014). Heartwood extract of Acacia catechu induces apoptosis in human breast carcinoma by altering Bax/Bcl-2 ratio. Pharmacogn Mag, 10: 27-33.
[75] Ghate N. B., Hazra B., Sarkar R., Chaudhri D., Mandal N. (2014). Alteration of Bax/Bcl-2 ratio contributes to Terminalia belerica induced apoptosis in human lung and breast carcinoma. In Vitro Cell Dev Biol Anim, 50: 527-537.
[76] Kar I., Majumder H. K., Chattopadhyaya R. (2017). Extracts of Seven Indian Plants Inhibit Human Topoisomerase I and Partially Inhibit Human Topoisomerase II. Mol Enz Drug Tar, 2: 5-11.
Cite This Article
  • APA Style

    Lenny Mwagandi Chimbevo, Gibson Kamau Gicharu, Fredrick x Mwamburi Mjomba, Suliman Essuman. (2021). DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits. Biochemistry and Molecular Biology, 6(3), 58-66. https://doi.org/10.11648/j.bmb.20210603.14

    Copy | Download

    ACS Style

    Lenny Mwagandi Chimbevo; Gibson Kamau Gicharu; Fredrick x Mwamburi Mjomba; Suliman Essuman. DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits. Biochem. Mol. Biol. 2021, 6(3), 58-66. doi: 10.11648/j.bmb.20210603.14

    Copy | Download

    AMA Style

    Lenny Mwagandi Chimbevo, Gibson Kamau Gicharu, Fredrick x Mwamburi Mjomba, Suliman Essuman. DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits. Biochem Mol Biol. 2021;6(3):58-66. doi: 10.11648/j.bmb.20210603.14

    Copy | Download

  • @article{10.11648/j.bmb.20210603.14,
      author = {Lenny Mwagandi Chimbevo and Gibson Kamau Gicharu and Fredrick x Mwamburi Mjomba and Suliman Essuman},
      title = {DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits},
      journal = {Biochemistry and Molecular Biology},
      volume = {6},
      number = {3},
      pages = {58-66},
      doi = {10.11648/j.bmb.20210603.14},
      url = {https://doi.org/10.11648/j.bmb.20210603.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bmb.20210603.14},
      abstract = {Some plants metabolites serve as antiprotozoal and antitumour by binding to nuclear enzyme; DNA Topo I affecting DNA function and cell survival. This study was aimed at screening DNA binding interactions and DNA Topo I inhibitory activity of crude extracts from fruits of Annona muricata (L) and Annona squamosa (L) which can form the basis of developing efficacious, safe and low cost antiprotozoal and antitumor agents. Aqueous, Methanolic, Ethyl acetate and Hexane extracts from fruits of two hypothesized antiprotozoal and antitumour plants; Annona muricata (L) and Annona squamosa (L) were screened for DNA-binding interaction and DNA Topo I inhibition. For DNA-methyl green test, 50 µL crude extracts were incubated with 200 μL DNA-methyl green in darkness at 25°C for 24 hours. Absorbance decrease at 650 nm using UV-vis spectrophotometer was calculated as a percentage of untreated DNA-methyl green value whereas with IC50 calculated by regression analysis. For DNA Topo I inhibitory activity, crude extracts were incubated in 10 µg/mL with 0.5 µg of supercoiled pBR322 DNA and 1U of DNA Topo I at 37°C for 2 hours, reaction terminated using stop buffer containing 3% SDS, 60 mM EDTA, 50% glycerol, 0.25% bromophenol blue. Products were determined by electrophoresis on 1% agarose gel in Tris-acetate-EDTA (TAE) running buffer at 65 V/cm for 2 hours. 24 extracts were studied, percentage decrease in absorbance were between 18.14±2.67 - 38.06±1.47 (Aqueous), 17.14±2.67 - 41.01±1.09% (Methanolic), 9.05±1.67 - 20.50±2.01% (Ethyl acetate) and 4.04±1.12 - 10.09±1.39% (Hexane)., IC50 values were between 50 μg/mL – 100 μg/mL (6), 100 μg/mL – 150 μg/mL (8), 150 μg/mL – 200 μg/mL (7) and 50 between 62.97±3.37 μg/mL - 131.37±10.77 μg/mL. The extracts of A. muricata and A. squamosa showed DNA Topo I inhibitory activities by inhibiting the relaxation of supercoiled DNA pBR322. However, further studies need to be conducted on the purified fractions of aqueous and methanolic extracts.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - DNA Binding Interactions and DNA Topoisomerase I Inhibition Activities of Crude Extracts from Annona Squamosa (L.) and Annona Muricata (L.) Fruits
    AU  - Lenny Mwagandi Chimbevo
    AU  - Gibson Kamau Gicharu
    AU  - Fredrick x Mwamburi Mjomba
    AU  - Suliman Essuman
    Y1  - 2021/08/13
    PY  - 2021
    N1  - https://doi.org/10.11648/j.bmb.20210603.14
    DO  - 10.11648/j.bmb.20210603.14
    T2  - Biochemistry and Molecular Biology
    JF  - Biochemistry and Molecular Biology
    JO  - Biochemistry and Molecular Biology
    SP  - 58
    EP  - 66
    PB  - Science Publishing Group
    SN  - 2575-5048
    UR  - https://doi.org/10.11648/j.bmb.20210603.14
    AB  - Some plants metabolites serve as antiprotozoal and antitumour by binding to nuclear enzyme; DNA Topo I affecting DNA function and cell survival. This study was aimed at screening DNA binding interactions and DNA Topo I inhibitory activity of crude extracts from fruits of Annona muricata (L) and Annona squamosa (L) which can form the basis of developing efficacious, safe and low cost antiprotozoal and antitumor agents. Aqueous, Methanolic, Ethyl acetate and Hexane extracts from fruits of two hypothesized antiprotozoal and antitumour plants; Annona muricata (L) and Annona squamosa (L) were screened for DNA-binding interaction and DNA Topo I inhibition. For DNA-methyl green test, 50 µL crude extracts were incubated with 200 μL DNA-methyl green in darkness at 25°C for 24 hours. Absorbance decrease at 650 nm using UV-vis spectrophotometer was calculated as a percentage of untreated DNA-methyl green value whereas with IC50 calculated by regression analysis. For DNA Topo I inhibitory activity, crude extracts were incubated in 10 µg/mL with 0.5 µg of supercoiled pBR322 DNA and 1U of DNA Topo I at 37°C for 2 hours, reaction terminated using stop buffer containing 3% SDS, 60 mM EDTA, 50% glycerol, 0.25% bromophenol blue. Products were determined by electrophoresis on 1% agarose gel in Tris-acetate-EDTA (TAE) running buffer at 65 V/cm for 2 hours. 24 extracts were studied, percentage decrease in absorbance were between 18.14±2.67 - 38.06±1.47 (Aqueous), 17.14±2.67 - 41.01±1.09% (Methanolic), 9.05±1.67 - 20.50±2.01% (Ethyl acetate) and 4.04±1.12 - 10.09±1.39% (Hexane)., IC50 values were between 50 μg/mL – 100 μg/mL (6), 100 μg/mL – 150 μg/mL (8), 150 μg/mL – 200 μg/mL (7) and 50 between 62.97±3.37 μg/mL - 131.37±10.77 μg/mL. The extracts of A. muricata and A. squamosa showed DNA Topo I inhibitory activities by inhibiting the relaxation of supercoiled DNA pBR322. However, further studies need to be conducted on the purified fractions of aqueous and methanolic extracts.
    VL  - 6
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Pure and Applied Science, School of Applied and Health Sciences, Technical University of Mombasa, Mombasa, Kenya

  • Department of Pure and Applied Science, School of Applied and Health Sciences, Technical University of Mombasa, Mombasa, Kenya

  • Department of Pure and Applied Science, School of Applied and Health Sciences, Technical University of Mombasa, Mombasa, Kenya

  • Department of Medical Microbiology, Medical School, Mount Kenya University, Thika, Kenya

  • Sections